In Vitro Imaging and in Vivo Liver Targeting with Carbohydrate Capped Quantum Dots
- 27 January 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (6) , 2110-2112
- https://doi.org/10.1021/ja807711w
Abstract
PEGylated quantum dots (QDs) capped with d-mannose, d-galactose, and d-galactosamine have been synthesized. The stable, high quantum yield fluorescence of QDs was exploited to study specific carbohydrate−protein interactions in vitro and in vivo.Keywords
This publication has 35 references indexed in Scilit:
- Dynamic metabonomic analysis of BALB/C mice with different outcomes after D-galactosamine/lipopolysaccharide-induced fulminant hepatic failureLiver Transplantation, 2008
- Monovalent, reduced-size quantum dots for imaging receptors on living cellsNature Methods, 2008
- Compact Biocompatible Quantum Dots Functionalized for Cellular ImagingJournal of the American Chemical Society, 2008
- Compact Cysteine-Coated CdSe(ZnCdS) Quantum Dots for in Vivo ApplicationsJournal of the American Chemical Society, 2007
- Mannosylated semiconductor quantum dots for the labeling of macrophagesJournal of Controlled Release, 2007
- The mannose receptor on murine liver sinusoidal endothelial cells is the main denatured collagen clearance receptorHepatology, 2007
- The Fluorescent Toolbox for Assessing Protein Location and FunctionScience, 2006
- Quantum Dot-Based Multiplexed Fluorescence Resonance Energy TransferJournal of the American Chemical Society, 2005
- Near-infrared fluorescent type II quantum dots for sentinel lymph node mappingNature Biotechnology, 2003
- Self-Assembly of CdSe−ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant ProteinJournal of the American Chemical Society, 2000